Inovalon’s Post

Does Medicare Advantage offer better outcomes than Medicare Fee-for-Service? Watch this on-demand webinar featuring Boris Vabson, Ph.D., Research Faculty, Harvard Medical School; Christie Teigland, Ph.D., VP, Research Science and Advanced Analytics, Inovalon; and Susan Dentzer, M.S., President and CEO, America's Physician Groups (APG), for an in-depth look at the Inovalon and Harvard research on Medicare Advantage plans. Gain insights on utilization and efficiency rates under MA compared to Medicare FFS. Watch now: https://ow.ly/p2Px50Se80X #MedicareAdvantage

Congrats to Greenough client Inovalon for their work with Harvard Medical School as they launch their first study in a series aiming to uncover the underlying factors influencing enrollment in Medicare Advantage or Fee-For-Service Medicare when transitioning to Medicare coverage. This first-of-its-kind study is made possible by Inovalon's longitudinally matched dataset, allowing researchers to track a given individual's health and utilization both before and after Medicare enrollment, across both commercial and Medicare coverage. Click the link to read the study and learn more! https://hubs.li/Q01Y3CCJ0

Medicare Advantage now covers over half of Medicare beneficiaries and accounts for over $350 billion in expenditures annually1. Yet, there is limited understanding of how utilization and efficiency under MA compare to Medicare Fee-for-Service (FFS), especially after adjusting for enrollment differences across the two programs. This webinar is the second in a series authored by researchers at Inovalon and Harvard Medical School. Learn about the groundbreaking findings that reveal differences in utilization and efficiency between MA and FFS. Register here ⏩ https://ow.ly/4HlT50QfFtk #MedicareAdvantage

How does the utilization and efficiency under Medicare Advantage compare to Medicare Fee-for-Service (FFS), especially after adjusting for enrollment differences across the 2 programs? Join our upcoming webinar featuring experts from Harvard Medical School and Inovalon for an engaging session filled with our latest research findings, innovative strategies, and in-depth analysis of MA plan design. Secure your spot today: https://ow.ly/He8Q50Rbl3g #MedicareAdvantage 

The American Medical Association Physician Practice Information (PPI) Survey is nearing completion (June 30), and we urgently need all selected physicians to actively engage in this effort. #ASEAdvocacy The intent of the survey, which has been endorsed by over 170 medical societies and other healthcare associations, is to collect updated and accurate data on practice costs which are key element of physician payment. These data have not been updated since last collected over 15 years ago. It is critically important to update these data to ensure accurate payment.

The American Medical Association Physician Practice Information (PPI) Survey is nearing completion (June 30), and we urgently need all selected physicians to actively engage in this effort. #ASEAdvocacy The intent of the survey, which has been endorsed by over 170 medical societies and other healthcare associations, is to collect updated and accurate data on practice costs which are key element of physician payment. These data have not been updated since last collected over 15 years ago. It is critically important to update these data to ensure accurate payment.

Uncover the reasons behind the higher utilization rates in Medicare Advantage plans compared to Medicare Fee-for-Service plans. Get the details in our latest Harvard Medical School and Inovalon white paper. Read More: ow.ly/uEET30sCVns #MedicareAdvantage

📢 Introducing one of our first CDS Ultimate Heroes, Kate Rothenberg, MSN, RN, AGCNS-BC, CCRN, Clinical Decision Support Manager at Community Health Network, Central Indiana. 🦸♀️   “Fortunately, as we have learned at Community, optimizing CDS becomes easier the more it is conducted and the benefits multiply exponentially. We have just scratched the surface with optimizing our medication-related alerts and look forward to more improvements in the coming years with the supportive guidance of FDB PatientFirst solutions.”   Read more about Kate and how she is optimizing CDS at Community making her an FDB #CDSUltimateHero: https://bit.ly/4bxNPDD | #CDSHero #ClinicalDecisionSupport #OptimizingCDS #ClinicalGuidance #PtSafety

Welcome to the @American Clinical Laboratory Association’s #SALSA Day of Action! Today, we are urging Congress to enact the Saving Access to Laboratory Services Act this year. If Congress fails to take action, scheduled #Medicare reimbursement cuts may compromise access to clinical laboratory tests used to diagnose and manage common and chronic conditions.   Every day, clinical laboratory professionals produce accurate test results that give clinicians and patients the data they need to inform some of life’s most important health care decisions. The time to act is now – tell Congress to #StopLabCuts and enact SALSA before the end of this year: https://stoplabcuts.org.  

There's still time to register for the upcoming Indiana University - Kelley School of Business Life Sciences Collaboration Series event on February 16, to see how the 2022 Inflation Reduction Act could indirectly impact patients, providers, and companies in the life sciences industry. #lifesciences #healthcare #indiana